Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Markus Grammel
How to take advantage of both EPO prosecution and German enforcement
Europe is one of the most important markets for the life sciences and pharma industry and Germany is one of its key jurisdictions. As in the rest of Europe, the legal landscape in Germany in patent matters is highly complex, due to different degrees of harmonisation between European countries and a wide range of different options to protect intellectual property on a national and European level.
IP experts remain positive in the face of changes to the global life sciences landscape
Contributors to the latest edition of the IAM Guide to Life Sciences stress that, while AI has the potential to revolutionise the global life sciences landscape, its integration in the pharma industry and the growing threat of cybersecurity breaches pose significant challenges to those operating in this space. However, there are many opportunities of which rights holders can take advantage.
How to take advantage of both EPO prosecution and German enforcement
This is an Insight article, written by a selected partner as part of IAM's co-published content. Read more on Insight Europe is one of the most important markets for the life sciences and pharma industry and Germany is one of its key jurisdictions.
Sequence listings filed with divisional applications: new EPO practice
Introduction Background Introduction Since 1 July 2022, any divisional patent application that has been filed on or after that date at the European Patent Office (EPO) and that contains relevant nucleotide or amino acid sequences must include a sequence listing that complies with the new global sequence listing standard, WIPO Standard ST.26. This standard replaces WIPO Standard ST.25 (for further details, please see "New WIPO standard for sequence listings").
How to take advantage of both EPO prosecution and German enforcement
Europe is one of the most important markets for the life sciences and pharma industry , and Germany is one of its key jurisdictions. As in the rest of Europe, the legal landscape in Germany in patent matters is highly complex, due to different degrees of harmonisation between European countries and a wide range of different options to protect intellectual property on a national and European level.
IAM Life Sciences: Key issues for senior life sciences executives 2022
Markus Grammel and Elena Biselli Grünecker Patent Attorneys and Attorneys-at-Law 18 August 2022 Shutterstock\Mo Photography Berlin Second medical use claims protect the use of an already known substance or composition in a new therapeutic application. Given the immense costs that are associated with developing new chemical entities for therapy, the repurposing of already available drugs is an attractive approach for the pharmaceutical industry.
Markus Grammel and Elena Biselli Grünecker Patent Attorneys and Attorneys-at-Law 18 August 2022 Shutterstock\Mo Photography Berlin Second medical use claims protect the use of an already known substance or composition in a new therapeutic application. Given the immense costs that are associated with developing new chemical entities for therapy, the repurposing of already available drugs is an attractive approach for the pharmaceutical industry.
Anonymous oppositions to continue at EPO
September 20 2021 Grünecker | Intellectual Property - European Union Introduction Facts Decision Comment Introduction Following the grant of a European patent, there is a window of nine months – the so-called "opposition period" – during which oppositions can be filed against a granted patent and the revocation of the patent can be requested.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Markus
Contact Markus, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack